Arnon P. Kater

12.9k citations
225 papers · 5.5k indexed · 3 hit papers · h-index 38
Topics
Chronic Lymphocytic Leukemia Research (198 papers)Lymphoma Diagnosis and Treatment (87 papers)Immunodeficiency and Autoimmune Disorders (42 papers)

In The Last Decade

Arnon P. Kater

220 papers receiving 5.5k citations

Hit Papers

Venetoclax–Rituximab in Relapsed or Refractory Chronic Ly...2018202620202023201820202025100200300400500

Peers

Arnon P. Kater
Comparison fields: 5 of 105
  • Genetics 3.6k
  • Pathology and Forensic Medicine 2.2k
  • Immunology 2.0k
  • Oncology 1.5k
  • Molecular Biology 1.5k
Replace Eva Kimby with:
Eva Kimby Sweden
Gerassimos A. Pangalis Greece
Emilio Montserrat Spain
Sonali M. Smith United States
Julio Delgado Spain
Leslie A. Andritsos United States
Bertold Emmerich Germany
Guang Yang United States
Thierry Lamy France
Philip Schulman United States
Arnon P. Kater relative to Eva Kimby Sweden Eva Kimby's profile →
Citations per field
00.5×5.5×
Eva Kimby · 1×
Citations per year

Countries citing papers authored by Arnon P. Kater

Since Specialization
Citations

This map shows the geographic impact of Arnon P. Kater's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnon P. Kater with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnon P. Kater more than expected).

Fields of papers citing papers by Arnon P. Kater

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arnon P. Kater. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnon P. Kater. The network helps show where Arnon P. Kater may publish in the future.

Co-authorship network of co-authors of Arnon P. Kater

This figure shows the co-authorship network connecting the top 25 collaborators of Arnon P. Kater. A scholar is included among the top collaborators of Arnon P. Kater based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arnon P. Kater. Arnon P. Kater is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2
SINGLE-AGENT EPCORITAMAB LEADS TO DEEP RESPONSES IN PATIENTS (PTS) WITH RICHTER’S TRANSFORMATION (RT): PRIMARY RESULTS FROM THE EPCORE CLL-1 TRIAL
1
3 2
4 1
5 2
6 1
7 8
8 14
9 7
10 16
11 15
12 11
13 9
14 27
15 19
16 32
17 3
18 46
19 79
20 48

About Arnon P. Kater

Arnon P. Kater is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology, having authored 225 papers that have together received 5.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (198 papers), Lymphoma Diagnosis and Treatment (87 papers) and Immunodeficiency and Autoimmune Disorders (42 papers). The work is most often cited by research in Genetics (3.6k citations), Pathology and Forensic Medicine (2.2k citations) and Immunology (2.0k citations). Arnon P. Kater has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Eric Eldering, Marinus H. J. van Oers, Thomas J. Kipps, Barbara Eichhorst, Peter Hillmen, Sanne H. Tonino, Tadeusz Robak, John F. Seymour, Paolo Ghia and Mehrdad Mobasher. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026